Chinese Drug Regulator Accepts Hansoh Pharmaceutical's NDA for Cancer Adjuvant Therapy Drug
Chinese Drug Regulator Accepts Hansoh Pharmaceutical's NDA for Cancer Adjuvant Therapy Drug
中國藥品監督管理局接受漢森藥業的新藥申請，用於癌症輔助治療藥物。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊